Advertisement
Advertisement

TYRA

TYRA logo

Tyra Biosciences, Inc. Common Stock

30.87
USD
Sponsored
-1.47
-4.54%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

30.84

-0.03
-0.10%

TYRA Earnings Reports

Positive Surprise Ratio

TYRA beat 10 of 17 last estimates.

59%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.54
Implied change from Q3 25 (Revenue/ EPS)
--
/
+8.00%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+25.58%

Tyra Biosciences, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, TYRA reported earnings of -0.50 USD per share (EPS) for Q3 25, beating the estimate of -0.50 USD, resulting in a 1.48% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an increase of 8.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Tyra Biosciences, Inc. Common Stock reported EPS of -$0.50, beating estimates by 1.48%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.64%, changed from $14.82 before the earnings release to $14.28 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 11 analysts, Tyra Biosciences, Inc. Common Stock is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement